Track market-moving stories before they get noisy

New Philips Hue smart bulbs leverage Silicon Labs wireless technology to support both Matter and Zigbee, giving consumers more choice while preserving the premium Hue experience

, /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless connectivity, and Signify (Euronext: LIGHT), a world leader in lighting, today announced their collaboration to bring concurrent multiprotocol (CMP) communications to select Philips Hue smart bulbs, enabling support for both Zigbee and Matter over Thread concurrently on a single device.

Bringing Greater Choice to the Smart Home

The collaboration allows Philips Hue users to benefit from the simplicity and interoperability of Matter while continuing to access the advanced features, immersive experiences, and deep ecosystem integration that have made Hue a leading smart lighting platform.

As smart homes become increasingly diverse, consumers want products that work seamlessly with the platforms they already use—whether that's Apple Home, Amazon Alexa, Google Home, Samsung SmartThings, or the Philips Hue ecosystem. By leveraging Silicon Labs' MG26 and SiMG301 wireless SoCs, Signify is enabling a new generation of Hue smart bulbs designed to deliver greater flexibility without compromising the premium lighting experiences consumers expect from Philips Hue.

"Philips Hue aims to transform how users use lighting inside their home whether it be for ambiance creation, convenience or entertainment. A big part of achieving this is to remove complexity for consumers while continuing to deliver the exceptional lighting experiences. Matter represents an important step forward for the smart home industry because it makes connected devices easier to set up and use," said George Yianni, Chief Technology Officer Philips Hue at Signify. "Our collaboration with Silicon Labs allows us to support the interoperability consumers want through Matter while preserving the advanced capabilities, entertainment experiences, and innovation available through the Hue ecosystem."

Combining Matter Simplicity with the Hue Experience

Philips Hue delivers a rich and reliable ecosystem with unique differentiated features and experiences including dynamic scenes, entertainment synchronization, automation capabilities, and immersive lighting experiences based on ZigBee technology. Matter was created to simplify smart home connectivity by enabling devices from different brands and platforms to work together more easily. With Matter-enabled Hue bulbs, consumers can have the freedom to integrate directly into leading smart home ecosystems for everyday controls while still unlocking advanced lighting centric functionality within the Hue ecosystem.

Silicon Labs' concurrent multiprotocol technology makes this possible by enabling Zigbee and Matter over Thread to operate simultaneously on a single wireless device. Rather than forcing manufacturers or consumers to choose between protocols, CMP allows devices to participate in multiple ecosystems at the same time, helping bridge today's installed smart home infrastructure with tomorrow's interoperable Matter-based environments.

Powering the Next Generation of Connected Lighting

"The future of the smart home isn't about choosing one ecosystem over another—it's about giving consumers the freedom to use the products and platforms they prefer," said Ross Sabolcik, Senior Vice President of Product Lines at Silicon Labs. "Signify has been a leader in advancing both smart lighting innovation and Matter adoption. By combining Philips Hue's industry-leading lighting experiences with Silicon Labs' concurrent multiprotocol technology, we're helping create a smart home experience that is simpler, more flexible, and more intuitive for consumers."

The collaboration builds on a long-standing relationship between Silicon Labs and Signify and reflects a shared commitment to advancing open standards, interoperability, and user-centric innovation across the smart home industry.

Select Philips Hue smart bulbs leveraging Silicon Labs MG26 and SiMG301 wireless SoCs are available now or are being introduced across Philips Hue product lines. Currently these products require choosing ZigBee or Thread at commissioning time but the software update to enable concurrent operation will be rolled out later this year simplifying the experience for consumers.

About Signify

Signify (Euronext: LIGHT) is a world leader in lighting for professionals and consumers. They proudly bring to market some of the world's best lighting brands, from Signify, Philips, Philips Hue, Signify Interact, Signify Dynalite, Color Kinetics and many more. Their advanced products, connected systems and services unlock the extraordinary potential of light for brighter lives and a better world. In 2025, they had sales of EUR 5.8 billion, approximately 27,000 employees, and a presence in over 70 markets. They are in the Dow Jones Sustainability World Index, earned a CDP 'A' score for climate performance and transparency and hold the EcoVadis Platinum rating.

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers with the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in smart home, industrial IoT, and smart cities markets. Learn more at https://www.silabs.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/signify-enhances-philips-hue-matter-support-through-collaboration-with-silicon-labs-302806896.html

SOURCE Silicon Labs

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT)'s merger with Marine Products Corporation. Upon completion of the proposed transaction, MasterCraft shareholders will own 66.5% of the combined company. If you are a MasterCraft shareholder, click here to learn more about your legal rights and options.

Silicon Laboratories Inc. (NASDAQ: SLAB)'s sale to Texas Instruments for $231.00 per share in cash. If you are a Silicon shareholder, click here to learn more about your legal rights and options.

Marine Products Corporation (NYSE: MPX)'s sale to MasterCraft Boat Holdings, Inc. for $2.43 per share in cash and 0.232 shares of MasterCraft common stock for each share of Marine. If you are a Marine shareholder, click here to learn more about your rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the European biotechnology company focused on gene therapies for age-related diseases, has reported that positive safety and efficacy signals from its SLAB trial have been maintained three months after the initial dosing period, with no adverse events observed.

The SLAB (Sarcopenia and Longevity in Aged Beagles) trial is evaluating Genflow's proprietary SIRT6 centenarian gene therapy in aged dogs, targeting sarcopenia, the age-related loss of muscle mass and strength that also affects humans.

The company said improvements across multiple independent endpoints remained consistent with earlier observations reported in February 2026, while control animals continued to show expected age-related decline.

The therapy targets SIRT6, a gene associated with longevity that is found to be more active in centenarians, and is delivered via gene therapy to restore or enhance its function in ageing subjects.

The trial is ongoing, with all animals continuing to be monitored, and completion is anticipated at the end of July 2026.

Additional analyses, including methylation clock assessment, a method of estimating biological age at the cellular level, and muscle histology, the microscopic examination of tissue structure, are in progress and are expected to provide further mechanistic insight into the therapy's effects.

Chief executive Eric Leire said the follow-up data extended the company's understanding beyond initial efficacy and into persistence of effect.

"The consistency of improvements across multiple functional endpoints, together with the continued absence of safety concerns, strengthens our confidence that SIRT6 gene therapy is delivering a sustained biological impact," he said.

Genflow said it was engaging with prospective partners in the animal health sector to explore licensing, co-development and commercialisation opportunities for its SIRT6 platform.

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO, Dr Eric Leire, talked with Proactive about encouraging results from the SLAB (Sarcopenia and Longevity in Aged Beagles) trial, highlighting sustained efficacy and safety following treatment.

Leire explained that one of the most significant findings is the durability of the therapy’s effects. Even three months after stopping treatment, the benefits observed in the dogs have been maintained.

He noted, "We stopped administration three months ago... and that's exactly what we see, both in terms of safety and in terms of efficacy." This persistence is a key milestone for gene therapy, as it could shift treatment from a repeated or chronic approach to a potential one-time intervention.

The durability of response also has broader implications for other indications Genflow Biosciences Ltd is pursuing. Leire indicated that the results support expectations for similar long-lasting effects in future applications, including MASH.

While clinical endpoints are already showing promising outcomes, the company is awaiting additional data from blood analyses and biopsies to complement these findings.

These results could further validate the therapy’s impact, including potential reductions in biological age. The existing data has already enabled early discussions with animal health companies regarding potential partnerships.

Proactive: Eric, very good to speak with you. The results in three months look encouraging. But what's actually changing in these dogs day to day that tells you the therapy's working?

Dr Eric Leire: What we notice now is the duration of effect. We stopped administration three months ago, and it was important to see if the benefit we noticed at the end of treatment would be maintained. That's exactly what we see, both in terms of safety and in terms of efficacy. So it's very good news.

Proactive: You mentioned persistence of effects. Why is durability such a critical piece of the puzzle for a gene therapy like this?

Dr Eric Leire: It changes everything because for the customer, it could be one therapy where you gain long-term benefit, rather than a chronic treatment. In terms of cost and convenience, it makes a totally different product. We are very happy to see this duration of effect. It’s also very interesting for other indications we are pursuing, because it allows us, for example, for MASH, to think we will have the same kind of duration of effect after therapy.

Proactive: You're still four months from completing the trial. What key data points are you waiting on, and what would a strong result look like?

Dr Eric Leire: What we have now is mostly clinical endpoints that matter to dog owners. We still need blood analysis and biopsy analysis as complementary data. The clinical data is already very promising and allow us to start negotiations with animal health companies. We want to outsource the product. It will be a nice confirmation if we see a decrease in biological age in the treated group.

Proactive: Thank you very much for your time.

Wireless IoT leader delivers $214 million in revenue and non-GAAP EPS of $0.53

, /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the first quarter, which ended April 4, 2026.

"The Silicon Labs team delivered a strong start to 2026 with revenue of $214 million and meaningful year-over-year improvements in both gross margin and profitability," said Matt Johnson, President and Chief Executive Officer.

"Over the course of the quarter we saw an acceleration in bookings with declining inventory positions at our distributors and end customers, led by our broad industrial business. Design win momentum continued during the first quarter, exceeding both our internal targets and our 2025 run rate, which was a prior record year for the company. This performance underscores the breadth and depth of our innovative product portfolio across end applications.

Our leading indicators point to both near- and long-term strength, with book-to-bill ratio at a multi-year high and two quarters of record design wins, reinforcing our conviction in Silicon Labs' durable growth trajectory. At the same time, our proposed merger with Texas Instruments continues to advance, and we remain focused on disciplined execution and delivering for our customers."

First Quarter Financial Highlights

Revenue was $214 million, up 20% year-over-year Industrial & Commercial revenue was $128 million, up 33% year-over-year Strength in electronic shelf labels and smart metering end applications Home & Life revenue was $86 million, up 5% year-over-year Medical end applications revenue grew by 21% year-over-year Results on a GAAP basis:

GAAP gross margin was 59.5% GAAP operating expenses were $144 million GAAP operating loss was $17 million GAAP effective tax rate was (16.1)% GAAP diluted loss per share was $(0.48) Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, acquisition-related costs, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

Non-GAAP gross margin was 59.7% Non-GAAP operating expenses were $109 million Non-GAAP operating income was $18 million Non-GAAP effective tax rate was 18%, which is the expected long-term rate for the remainder of the year Non-GAAP diluted earnings per share was $0.53 Due to the announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs has suspended providing forward-looking guidance.

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding Silicon Labs' current expectations, which are based on its current views and assumptions. The words "believe", "estimate", "expect", "intend", "anticipate", "plan", "project", "will", and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements, although the absence of such words does not necessarily mean a statement is not forward-looking. These forward-looking statements include, but are not limited to, Silicon Labs' expectations regarding its near- and long-term strength and durable growth trajectory and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations that are expressed or implied herein. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: our ability to complete the merger with Texas Instruments within the time frame expected, or at all, as well as potential disruptions in our business and restrictions on our activities during the pendency of the merger; fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs' distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs' products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the "S" symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(Unaudited)

Three Months Ended

April 4,
2026

April 5,
2025

Revenues

$       213,500

$       177,714

Cost of revenues

86,502

79,937

Gross profit

126,998

97,777

Operating expenses:

Research and development

88,594

88,219

Selling, general and administrative

55,486

41,638

Operating expenses

144,080

129,857

Operating loss

(17,082)

(32,080)

Other income (expense):

Interest income and other, net

3,626

3,793

Interest expense

(232)

(284)

Loss before income taxes

(13,688)

(28,571)

Provision for income taxes

2,209

1,899

Net loss

$        (15,897)

$        (30,470)

Loss per share:

Basic

$          (0.48)

$          (0.94)

Diluted

$          (0.48)

$          (0.94)

Weighted-average common shares outstanding:

Basic

32,963

32,465

Diluted

32,963

32,465

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs' GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs' financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)

Three Months Ended

April 4, 2026

Non-GAAP Income
Statement Items

GAAP

Measure

GAAP

Percent of

Revenue

Stock

Compensation

Expense

Intangible
Asset

Amortization

Acquisition-
Related Costs

Other Costs

Non-GAAP

Measure

Non-GAAP

Percent of

Revenue

Revenues

$ 213,500

Gross profit

126,998

59.5 %

$         442

$          —

$          —

$   —

$ 127,440

59.7 %

Research and development

88,594

41.5 %

11,416

2,295

—

664

74,219

34.8 %

Selling, general and
administrative

55,486

26.0 %

9,197

—

11,213

—

35,076

16.4 %

Operating expenses

144,080

67.5 %

20,613

2,295

11,213

664

109,295

51.2 %

Operating income (loss)

(17,082)

(8.0 %)

21,055

2,295

11,213

664

18,145

8.5 %

Three Months Ended

April 4, 2026

Non-GAAP Earnings (Loss)
Per Share

GAAP

Measure

Stock

Compensation

Expense*

Intangible

Asset

Amortization*

Acquisition-
Related
Costs*

Other

Costs*

Income

Tax

Adjustments**

Non-

GAAP

Measure

Net income (loss)

$  (15,897)

$     21,055

$       2,295

$      11,213

$     664

$       (1,668)

$     17,662

Shares Excluded Due to Net Loss

Diluted shares outstanding

32,963

585

33,548

Diluted earnings (loss) per share

$    (0.48)

$        0.53

*  Represents pre-tax amounts

**  Represents the application of an 18% non-GAAP tax rate

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

April 4,
2026

January 3,
2026

Assets

Current assets:

Cash and cash equivalents

$       383,089

$       364,222

Short-term investments

55,767

79,400

Accounts receivable, net

77,120

64,513

Inventories

103,232

95,566

Prepaid expenses and other current assets

57,113

70,316

Total current assets

676,321

674,017

Property and equipment, net

131,821

128,643

Goodwill

376,389

376,389

Other intangible assets, net

20,836

23,130

Other assets, net

61,094

67,138

Total assets

$     1,266,461

$     1,269,317

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

$         56,384

$         50,717

Deferred revenue and returns liability

9,822

5,359

Other current liabilities

66,273

87,711

Total current liabilities

132,479

143,787

Other non-current liabilities

35,448

31,112

Total liabilities

167,927

174,899

Commitments and contingencies

Stockholders' equity:

Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued

—

—

Common stock – $0.0001 par value; 250,000 shares authorized; 32,968 and 32,955
shares issued and outstanding at April 4, 2026 and January 3, 2026, respectively

3

3

Additional paid-in capital

177,551

157,402

Retained earnings

920,917

936,814

Accumulated other comprehensive income

63

199

Total stockholders' equity

1,098,534

1,094,418

Total liabilities and stockholders' equity

$     1,266,461

$     1,269,317

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Three Months Ended

April 4,
2026

April 5,
2025

Operating Activities

Net loss

$        (15,897)

$        (30,470)

Adjustments to reconcile net loss to net cash provided by operating activities:

Depreciation of property and equipment

6,047

6,248

Amortization of other intangible assets

2,295

5,437

Stock-based compensation expense

21,055

19,714

Deferred income taxes

1,153

(1,514)

Changes in operating assets and liabilities:

Accounts receivable

(12,608)

2,412

Inventories

(7,616)

22,098

Prepaid expenses and other assets

6,813

2,973

Accounts payable

3,387

9,234

Other current liabilities and income taxes

(7,415)

11,870

Deferred revenue and returns liability

4,463

3,405

Other non-current liabilities

3,257

(3,279)

Net cash provided by operating activities

4,934

48,128

Investing Activities

Purchases of marketable securities

—

(19,728)

Sales of marketable securities

—

10,005

Maturities of marketable securities

23,461

10,675

Purchases of property and equipment

(9,837)

(4,852)

Proceeds from capital-related government incentives

1,265

—

Net cash provided by (used in) investing activities

14,889

(3,900)

Financing Activities

Payment of taxes withheld for vested stock awards

(956)

(958)

Net cash used in financing activities

(956)

(958)

Increase in cash and cash equivalents

18,867

43,270

Cash and cash equivalents at beginning of period

364,222

281,607

Cash and cash equivalents at end of period

$       383,089

$       324,877

SOURCE Silicon Labs

Dual-Band EFR32FG28 Wireless SoC Enables Secure, Interoperable RF Mesh Networking for India's Smart Energy Meter Rollout

, /PRNewswire/ -- Comminent®, an innovator in next-generation IoT communication network platforms, and Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, today announced a major milestone for India's smart grid infrastructure with the successful shipment of over 500,000 Wi-SUN-compliant communication modules powered by Silicon Labs' EFR32FG28 Wireless SoC.

The FG28 dual-band SoC from Silicon Labs supports sub-Ghz wireless protocols and Bluetooth LE.

Comminent's FG28-equipped module. Scaling Wi-SUN for India's Smart Grid Modernization
India's Revamped Distribution Sector Scheme (RDSS) is driving one of the world's largest infrastructure transformations. To support this ambitious smart meter rollout, the Bureau of Indian Standards (BIS) officially adopted the global Wi-SUN Field Area Network (FAN) specification (IEEE 2857-2021 and ISO/IEC/IEEE 32857:2026) as the national standard (IS 18010) for smart meter RF communication networks. This standardization ensures secure, interoperable wireless mesh networks for large-scale Advanced Metering Infrastructure (AMI), smart cities, and IoT applications.

"Comminent's 500,000-unit milestone highlights the growing adoption of Wi-SUN in large-scale deployments," said Ross Sabolcik, Senior Vice President of Product Lines at Silicon Labs. "We are proud to partner with Comminent to provide the robust, scalable, and highly secure underlying technology needed to support India's ambitious grid modernization efforts and deliver reliable connectivity to millions."

Solving Complex Deployment Challenges at Scale
Comminent's deep focus on solving India's complex deployment challenges is central to delivering scalable and reliable rollouts. As utilities move closer to real-time monitoring and grid resilience, interoperable and self-healing networks like Wi-SUN are functioning as the primary infrastructure for large-scale deployment.

"India's smart metering rollout is one of the largest infrastructure transformations, and this milestone reflects the growing shift toward scalable, utility-grade communication networks like Wi-SUN," said Amarjeet Kumar, Founder & CEO of Comminent. "Our collaboration with Silicon Labs strengthens our ability to deliver high-performance communication modules engineered for advanced smart grid deployments."

Built on the EFR32FG28 Wireless SoC for Resilient, Utility-Grade Connectivity
To meet these demands, Comminent's communication module is powered by Silicon Labs' EFR32FG28 Wireless SoC, architected specifically for large-scale smart grid and industrial IoT applications. The EFR32FG28 platform enables reliable, long-range connectivity in demanding field environments, offering key advantages including:

Optimized Dual-Band Connectivity: Combines a high-performance, long-range Sub-GHz radio optimized for India's RF environment with a 2.4 GHz Bluetooth LE radio for increased design flexibility. Resilient Processing & Infrastructure: Features a high-performance multi-core architecture with dedicated ARM cores for application processing, radio, and edge intelligence, complemented by ample memory to deliver robust mesh networking performance in dense urban and geographically distributed deployments. Enterprise-Grade Security: Powered by Silicon Labs' Secure Vault™ technology with PSA Level 3 certification, delivering secure key storage, anti-tamper capabilities, and advanced hardware cryptographic acceleration. This combination enables utilities to deploy scalable, secure, and future-ready Wi-SUN networks capable of supporting millions of endpoints. With capabilities proven in India's large-scale deployments, Comminent is expanding into global smart grid markets, including the United States, Japan, and emerging energy-transition regions.

To learn more about how Silicon Labs is powering the next generation of smart grids, explore the EFR32FG28 Wireless SoC and our Wi-SUN solutions.

About Comminent
Comminent Pvt Ltd, headquartered in Bengaluru, Karnataka, offers IPv6-compliant open standards-based machine-to-machine (M2M) communication solutions that are device agnostic and built to provide high reliability. The company's state-of-the-art device management platform is powered by AI/ML tools combined with edge-computing technologies to ensure faster decision-making and trigger control actions based on predefined policies. Comminent has proven expertise in large-scale IoT networks, providing a variety of communication solutions and engineering tools to silicon vendors, module and product OEMs, system integrators, and service providers.

About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers with the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in smart home, industrial IoT, and smart cities markets. Learn more at https://www.silabs.com.

SOURCE Silicon Labs